The original success of Sildenafil undeniably revolutionized the drug landscape, but betting in companies primarily reliant on unbranded versions presents a uncertain picture. While early profits were impressive, the expiration of patents and the rise of discounted alternatives have weakened the customer base. Thus, a thorough analysis of present r